Navigation Links
Semafore Achieves a Preclinical Milestone with SF2626, a PI3K-MEK Dual Pathway Kinase Inhibitor
Date:3/17/2009

INDIANAPOLIS, March 17 /PRNewswire/ -- Semafore Pharmaceuticals, Inc. announced today that it has achieved proof of concept in its CRIMP (Control Resulting from Inhibiting Multiple Pathways) kinase platform by designing a small molecule that was demonstrated to inhibit members of both the PI3K (Phosphoinositide-3-kinase) pathway and the Ras-MAPK (Ras-mitogen activated protein kinase) pathway. Specifically, SF2626 has demonstrated the ability to inhibit both PI3K and MEK, the key component of the RAS/RAF/MEK/ERK pathway. Both PI3K and MEK are frequently activated in human tumors and are thus considered high value targets in treating cancer. SF2626 is the first combination PI3K and MEK kinase inhibitor that, in preclinical studies, blocks both pathways simultaneously.

There is clear rationale for inhibiting both pathways in treating cancer. Both the PI3K pathway and the Ras-MAPK pathways have emerged as central conduits of cell signaling networks that regulate cell growth and survival. Recent scientific studies demonstrate that the Ras-MAPK pathway has the ability to cross-talk to the PI3K pathway thereby activating it and that in some cancers both pathways require inhibition to induce programmed cell death.

Additionally, clinical studies in cancer patients with KRAS mutations show that EGFR inhibitors alone are not sufficient to block the downstream activation of the Ras-MAPK pathway. In these patients, it may also be necessary to block both pathways to inhibit cancer cell growth.

With the evolving knowledge of cancer biology and further understanding of the mechanisms of drug resistance Semafore's CRIMP platform technology offers a distinctive approach to rational drug design for combination pathway kinase inhibitors.

Semafore's dual PI3K-MEK kinase inhibitor, SF2626, is a promising lead for targeting cancer. The Company is actively seeking a partner for the continued development
'/>"/>

SOURCE Semafore Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Semafores PI3 Kinase Inhibitor SF1126 is Active Against Tumor and Tumor Cells and Synergizes with Standard Chemotherapy Agents
2. Semafores SF1126 Exhibits Antitumor and Antiangiogenic Activity
3. Semafores PI3 Kinase Inhibitor SF1126 is a Vascular Targeted Conjugate in Phase I Clinical Trials in Solid Tumors and Multiple Myeloma
4. Semafore Pharmaceuticals Reports Positive Interim Results from a Phase I Study of SF1126, a Targeted Pan-PI3K Inhibitor, in Patients with Advanced Solid Tumors
5. Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors
6. SF1126, Semafores PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines
7. Large Blinded Clinical Study Achieves High Accuracy for the Diagnosis of Melanoma Using In Vivo Confocal Microscopy
8. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
9. Cethromycin Achieves All Endpoints in Second Pivotal Phase III Trial for Treatment of Pneumonia
10. PLC Systems Achieves Successful Early Conclusion of RenalGuard(TM) Pilot Safety Trial
11. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013  Lakeland Industries, Inc. (NASDAQ: ... protective clothing for industry, healthcare and to first responders ... its financial results for the fiscal 2013 fourth quarter ... 21, 2013 at stock market close and will conduct ... p.m. eastern. (Logo: http://photos.prnewswire.com/prnh/20120611/NY21959LOGO ) ...
(Date:5/17/2013)... N.C. , May 17, 2013  Technology ... organizations communicate internally. Faced with a constantly evolving ... strategies and tactics for communicating with internal executives. ... of all the strategies, tactics and tools that ... In a new study, Best Practices, LLC ...
(Date:5/17/2013)... , May 17, 2013  Sony Biotechnology Inc. ... SP6800 Spectral Analyzer (SP6800).  Sony will be exhibiting and ... will be held at the San Diego ... California , from May 20 - 22.  ... analytical system, incorporating commercial audio-visual technologies into new and ...
Breaking Medicine Technology:Lakeland Industries to Report Fiscal Fourth Quarter and Year End Financial Results and Conduct Conference Call 2Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness 2Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2
... Treated for Acute Coronary Syndromes,(ACS) Nearly Triples the ... March 26, 2007 /PRNewswire/ -- One-year findings,from the ... patients in the "Angiomax(R) (bivalirudin) alone" treatment,group had ... complicated standard therapy, confirming previous findings,which showed similar ...
... CSL Limited today,announced results from a study published in ... of a novel new,drug, CSL-111, to acutely raise HDL ... the coronary arteries of,patients with a recent episode of ... to describe unstable angina and myocardial,infarction (heart attack). It ...
Cached Medicine Technology:Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 2Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 3Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 4Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 5Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 6CSL Therapy That Mimics 'Good' Cholesterol May Reduce Plaque Volume,in Coronary Arteries 2CSL Therapy That Mimics 'Good' Cholesterol May Reduce Plaque Volume,in Coronary Arteries 3CSL Therapy That Mimics 'Good' Cholesterol May Reduce Plaque Volume,in Coronary Arteries 4
(Date:5/19/2013)... 2013 Fat Burning Furnace developed by ... provides people with fat burning diet plans, ... Fat Burning Furnace package, people will receive the Fat ... download quickly. The Fat Burning Furnace manual includes fat ... lean muscle mass. In addition, this book covers step-by-step ...
(Date:5/19/2013)... 19, 2013 The Fat Loss Code program ... secrets that help people get in shape, and gain ... shape. The program also is a natural fat loss system ... the author of this fat loss diet program claimed that ... can help people keep body fat off long-term. After Shawn ...
(Date:5/19/2013)... 2013 Passages Malibu, the leading non-12 ... announced this week the launch of a “Sobriety, Health, ... media channels. “We are always looking for new ... to get feedback regarding sobriety, what’s working for people, ... of the Passages Addiction Treatment Centers located ...
(Date:5/19/2013)... Minor fender benders and serious car accidents are common ... accident to respond appropriately to the situation. According ... from 2010, accidents, including car accidents, are the fifth ... 2005, automobile accident-related deaths cost over $70 ... drivers and passengers receive treatment in an emergency room ...
(Date:5/18/2013)... 2013 Daily Gossip issued a press release ... on their page. John Colston, Daily Gossip’s spokesperson, told the ... revolutionizing 14-Day Rapid Fat Loss Plan . , ... are healthy at a time when nutritionists and fat loss ... products. , The diet is based on the ...
Breaking Medicine News(10 mins):Health News:Fat Burning Diet | How “Fat Burning Furnace” Helps People Lose Their Weight Naturally And Fast – V-kool 2Health News:Weight Loss Secrets | How “The Fat Loss Code” Helps People Gain A Healthy Life And Get In Shape - Health Review 2Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 2Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 3Health News:Auto Accident Infographic Issued by d’Oliveira & Associates on Steps to Take After a Car Crash 2
... Sniffing out a new source of stem cells ... at the Salk Institute for Biological Studies, La Jolla, has ... from immune system tissue in the smell-sensing region of the ... a source of cells to treat brain disorders in which ...
... researchers who studied controversial aspects of Medicare spending ... award yesterday from the nation,s largest health services ... presented its 2011 Article of the Year Award ... the Center for Outcomes Research at The Children,s ...
... learn about the signs and symptoms of drug impairment ... Sam Houston State University (SHSU) June 14. The free, ... after Sept. 1, 2011., The program, funded by the ... employers, including human resources personnel, owners and executive staff. ...
... in the United States are cancer survivors. On average, their ... care of people who have never had cancer, according to ... and survive cancer are susceptible to later health complications and ... are considered cancer survivors from the moment they are diagnosed ...
... an increased risk of adverse pregnancy outcomes, suggests a ... in Minneapolis, Minn., at SLEEP 2011, the 25th Anniversary ... Results show that women with severe sleep apnea ... This increased prevalence was principally driven by a higher ...
... developed a tool to rapidly assess the risk of ... on psychiatric units. Ultimately, they hope to use ... behavior in schools and in the community. A ... the Child and Adolescent Aggression (BRACHA) tool is published ...
Cached Medicine News:Health News:JCI online early table of contents: June 13, 2011 2Health News:JCI online early table of contents: June 13, 2011 3Health News:JCI online early table of contents: June 13, 2011 4Health News:JCI online early table of contents: June 13, 2011 5Health News:JCI online early table of contents: June 13, 2011 6Health News:JCI online early table of contents: June 13, 2011 7Health News:JCI online early table of contents: June 13, 2011 8Health News:JCI online early table of contents: June 13, 2011 9Health News:JCI online early table of contents: June 13, 2011 10Health News:Hospital outcomes research named 'Article of the Year' 2Health News:Hospital outcomes research named 'Article of the Year' 3Health News:Drug recognition program available for Texas employers 2Health News:Cancer survivors spend more on health care 2Health News:Sleep apnea may increase the risk of adverse pregnancy outcomes 2Health News:Tool developed to predict violence and aggression in children and teens 2
... designed to meet the working and budgetary ... user to run set assays at the ... on this strip washer adjusts to wash ... Reliable, compact, and self-contained, offers aerosol and ...
... Labcyte miniGene LW is a new plate washing ... 96 and 384 channel microplates with flat, V-shaped ... with 8 or 16 channel nozzle heads. Simple ... breeze. An optional plate stacker is available for ...
... L/day of Type III Laboratory-grade Water, RiOs ... up to 8000 L/day of Type III ... Complete Purification and Control Unit, RiOs systems ... providing total control of all parameters within ...
... Produce Up to 8000 L/day of ... systems are designed to produce up to ... from potable tap feedwater., One Complete Purification ... integrated into a centralized system, providing total ...
Medicine Products: